JPS533509A - Preparation of tumor vaccine - Google Patents

Preparation of tumor vaccine

Info

Publication number
JPS533509A
JPS533509A JP8303276A JP8303276A JPS533509A JP S533509 A JPS533509 A JP S533509A JP 8303276 A JP8303276 A JP 8303276A JP 8303276 A JP8303276 A JP 8303276A JP S533509 A JPS533509 A JP S533509A
Authority
JP
Japan
Prior art keywords
preparation
tumor vaccine
vaccine
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8303276A
Other languages
English (en)
Japanese (ja)
Inventor
Henrii Rando Za Saado Jieimusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICROLOG Ltd
Original Assignee
MICROLOG Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICROLOG Ltd filed Critical MICROLOG Ltd
Publication of JPS533509A publication Critical patent/JPS533509A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP8303276A 1975-07-14 1976-07-14 Preparation of tumor vaccine Pending JPS533509A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59535375A 1975-07-14 1975-07-14

Publications (1)

Publication Number Publication Date
JPS533509A true JPS533509A (en) 1978-01-13

Family

ID=24382916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8303276A Pending JPS533509A (en) 1975-07-14 1976-07-14 Preparation of tumor vaccine

Country Status (4)

Country Link
JP (1) JPS533509A (de)
DE (1) DE2630380A1 (de)
FR (1) FR2317940A1 (de)
GB (1) GB1554446A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087174A (en) * 1996-12-26 2000-07-11 Johns Hopkins University, School Of Medicine Growth medium for primary pancreatic tumor cell culture

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059680A (en) * 1986-11-24 1991-10-22 Centocor, Inc. Method of isolating ca 125 antigen
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
CA2184132C (en) * 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087174A (en) * 1996-12-26 2000-07-11 Johns Hopkins University, School Of Medicine Growth medium for primary pancreatic tumor cell culture

Also Published As

Publication number Publication date
DE2630380A1 (de) 1977-02-03
FR2317940A1 (fr) 1977-02-11
GB1554446A (en) 1979-10-24

Similar Documents

Publication Publication Date Title
IL47177A0 (en) Antipregnancy vaccine
JPS5246031A (en) Preparation of arylamine
JPS51136772A (en) Preparation of high ciss1*44polybutadiene
GR60047B (en) Preparation process of 11-desoxy-16-aryloxy-omega-tetranorprostaglandins
GB1539457A (en) Preparation of d-mannitol
JPS51115427A (en) Preparation of ethylbenzole
JPS51131836A (en) Preparation of acetoacetylarylamide
JPS5251330A (en) Preparation of trichloromethyll trifluoromethyllbenzene
PT64945A (en) Preparation of therapeutic compounds
GB1551146A (en) Preparation of oxiranes
JPS5259118A (en) Preparation of trichloromethyll trifluoromethyllbenzene
IL49686A0 (en) Preparation of 3-phenoxybenzaldehydes
JPS533509A (en) Preparation of tumor vaccine
JPS5259119A (en) Preparation of trichloromethyll trifluoromethyllbenzene
IL50634A0 (en) Preparation of 2-amino-1-alcohols
GB1533134A (en) Preparation of nitroketene animals
JPS5273832A (en) Preparation of halogennitrobenzole
NZ181026A (en) Preparation of n-oxazol-2-ylcarboxamides
IL50150A (en) Preparation of 3-methoxymethyl-cephalosporins
JPS5279014A (en) Preparation of polysaccharideecontaining mushroom extract
JPS5223028A (en) Preparation of alpha* alpha* alpha** alpha** alphaapentachlorooooxylol
JPS51135228A (en) Preparation of leaffmold
JPS5274590A (en) Preparation of ammoooxidation catalysts
ZA763902B (en) Preparation of gamma-pyrones
IL49120A (en) Preparation of n-alkenyl-2-aminomethyl-pyrrolidines